Auxesis Pharma Information

Auxesis Pharma Holding AB (publ) is a Swedish pharmaceutical company specializing in topical pain relief and skin irritation treatments. Based on our own patents, we develop innovative OTC and RX medicines for both humans and animals – designed to act fast, provide lasting effect, and be easily accessible. Our first product platform, ASA.P®, is the world’s first stabilized liquid form of acetylsalicylic acid (ASA) for direct application on the skin. It offers rapid pain relief and anti-inflammatory effect in minutes – a breakthrough in a category where today’s alternatives provide only temporary cooling. With a clear roadmap of new products in development and a strong, experienced leadership team, Auxesis is building long-term value in the global market for topical pain relief. Our interdisciplinary expertise spans pharmaceutical R&D, regulatory processes, commercialization and market access – ensuring that innovation successfully reaches the end user. Our mission: redefine the global market for topical pain relief and improve quality of life for end users worldwide.